William S Harris1, Liana Del Gobbo2, Nathan L Tintle3. 1. OmegaQuant Analytics, LLC and Sanford School of Medicine, University of South Dakota, Sioux Falls, SD, USA. Electronic address: bill@omegaquant.com. 2. Stanford University School of Medicine, Palo Alto, CA, USA. 3. Department of Mathematics & Statistics, Dordt College, Sioux Center, IA, USA.
Abstract
BACKGROUND AND AIMS: A recent 19-cohort meta-analysis examined the relationships between biomarkers of omega-3 fatty acids and risk for coronary heart disease (CHD). That study did not, however, report hazard ratios (HRs) specifically as a function of erythrocyte eicosapentaenoic (EPA) plus docosahexaenoic (DHA) levels, a metric called the Omega-3 Index in which EPA + DHA content is expressed as a percent of total fatty acids. The Omega-3 Index has been used in several recent studies and is a validated biomarker of omega-3 fatty acid tissue levels, but additional data are needed to confirm (or refute) the originally-proposed clinical cut-points of <4% (higher risk) and 8%-12% (lower risk). METHODS: The present study was therefore undertaken using published data from this meta-analysis to estimate HRs per 1-SD increase in the Omega-3 Index and median quintile values for this metric across 10 of the cohorts for which the needed data were available. RESULTS: The overall mean (SD) for the Omega-3 Index in these 10 cohort studies was 6.1% (2.1%), and the HR for a 1-SD increase was 0.85 (95% confidence interval, 0.80-0.91). Median quintile 1 and 5 levels were 4.2% vs. 8.3%, respectively. Based on these values, we estimate that risk for fatal CHD would have been reduced by about 30% moving from an Omega-3 Index of 4%-8%. CONCLUSIONS: These findings support the use of <4% and >8% as reasonable therapeutic targets for the Omega-3 Index.
BACKGROUND AND AIMS: A recent 19-cohort meta-analysis examined the relationships between biomarkers of omega-3 fatty acids and risk for coronary heart disease (CHD). That study did not, however, report hazard ratios (HRs) specifically as a function of erythrocyte eicosapentaenoic (EPA) plus docosahexaenoic (DHA) levels, a metric called the Omega-3 Index in which EPA + DHA content is expressed as a percent of total fatty acids. The Omega-3 Index has been used in several recent studies and is a validated biomarker of omega-3 fatty acid tissue levels, but additional data are needed to confirm (or refute) the originally-proposed clinical cut-points of <4% (higher risk) and 8%-12% (lower risk). METHODS: The present study was therefore undertaken using published data from this meta-analysis to estimate HRs per 1-SD increase in the Omega-3 Index and median quintile values for this metric across 10 of the cohorts for which the needed data were available. RESULTS: The overall mean (SD) for the Omega-3 Index in these 10 cohort studies was 6.1% (2.1%), and the HR for a 1-SD increase was 0.85 (95% confidence interval, 0.80-0.91). Median quintile 1 and 5 levels were 4.2% vs. 8.3%, respectively. Based on these values, we estimate that risk for fatal CHD would have been reduced by about 30% moving from an Omega-3 Index of 4%-8%. CONCLUSIONS: These findings support the use of <4% and >8% as reasonable therapeutic targets for the Omega-3 Index.
Authors: Lara T Meital; Mark T Windsor; Rebecca M L Ramirez Jewell; Peter Young; Karl Schulze; Rebecca Magee; Jill O'Donnell; Pankaj Jha; Maria Perissiou; Jonathan Golledge; Tom G Bailey; Peter Brooks; Christopher D Askew; Fraser D Russell Journal: J Lipid Res Date: 2019-03-26 Impact factor: 5.922
Authors: Joel L Ramirez; Greg J Zahner; Kimberly A Spaulding; Sukaynah A Khetani; Nancy K Hills; Warren J Gasper; William S Harris; Beth E Cohen; S Marlene Grenon Journal: Lipids Date: 2019-03-18 Impact factor: 1.880
Authors: E Madison Sullivan; Edward Ross Pennington; Genevieve C Sparagna; Maria J Torres; P Darrell Neufer; Mitchel Harris; James Washington; Ethan J Anderson; Tonya N Zeczycki; David A Brown; Saame Raza Shaikh Journal: J Biol Chem Date: 2017-11-21 Impact factor: 5.157
Authors: Emily Wheeler; Mary Walsh-Wilcox; Meera Shah; Abinash Achrekar; Joe R Anderson; Mary K Walker Journal: Cardiovasc Toxicol Date: 2020-08-25 Impact factor: 3.231
Authors: Maite M Aldaya; Francisco C Ibañez; Paula Domínguez-Lacueva; María Teresa Murillo-Arbizu; Mar Rubio-Varas; Beatriz Soret; María José Beriain Journal: Foods Date: 2021-05-02
Authors: Michael I McBurney; Jeffrey B Blumberg; Rebecca B Costello; Manfred Eggersdorfer; John W Erdman; William S Harris; Elizabeth J Johnson; Susan Hazels Mitmesser; Robert C Post; Deshanie Rai; Leon J Schurgers Journal: Nutrients Date: 2021-05-28 Impact factor: 5.717